Mark C. Houston

4.5k total citations
101 papers, 3.2k citations indexed

About

Mark C. Houston is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Mark C. Houston has authored 101 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 28 papers in Surgery and 23 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Mark C. Houston's work include Blood Pressure and Hypertension Studies (26 papers), Nutritional Studies and Diet (18 papers) and Sodium Intake and Health (16 papers). Mark C. Houston is often cited by papers focused on Blood Pressure and Hypertension Studies (26 papers), Nutritional Studies and Diet (18 papers) and Sodium Intake and Health (16 papers). Mark C. Houston collaborates with scholars based in United States, Spain and Canada. Mark C. Houston's co-authors include Karen Harper, Ralph G. Hawkins, Stephen A. Hines, David Robertson, Carlos M. Ferrario, William H. Bestermann, James Reed, William Sun, T. A. Barringer and Dean A. Bramlet and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Medicine and American Heart Journal.

In The Last Decade

Mark C. Houston

94 papers receiving 3.0k citations

Peers

Countries citing papers authored by Mark C. Houston

Since Specialization

Citations

This map shows the geographic impact of Mark C. Houston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark C. Houston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark C. Houston more than expected).

Fields of papers citing papers by Mark C. Houston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark C. Houston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark C. Houston. The network helps show where Mark C. Houston may publish in the future.

Co-authorship network of co-authors of Mark C. Houston

This figure shows the co-authorship network connecting the top 25 collaborators of Mark C. Houston. A scholar is included among the top collaborators of Mark C. Houston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark C. Houston. Mark C. Houston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Voluntariness in First-in-Human Pig Kidney Xenotransplant Clinical Trials 2025 ·American Journal of Transplantation ·Mark C. Houston, Karen J. Maschke, Michael K. Gusmano, Elisa J. Gordon	0
2	Effects of S-Allylcysteine-Rich Garlic Extract and Dietary Inorganic Nitrate Formula on Blood Pressure and Salivary Nitric Oxide: An Open-Label Clinical Trial Among Hypertensive Subjects 2023 ·Cureus ·Mark C. Houston, Chen Chen, Christopher R. D’Adamo, Adonia E. Papathanassiu, Shawn J. Green	0
3	Fasting mimicking diet cycles versus a Mediterranean diet and cardiometabolic risk in overweight and obese hypertensive subjects: a randomized clinical trial 2023 ·SHILAP Revista de lepidopterología ·Amrendra Mishra, Maura Fanti, Xinzhou Ge, (unknown), Sebastian Brandhorst, Min Wei, Kurt Hong, Matteo Pellegrini, Hanno Pijl, Mark C. Houston, Valter D. Longo	3
4	Nutrition and Nutritional Supplements in the Management of Dyslipidemia—Part 1 2019 ·Alternative and Complementary Therapies ·Mark C. Houston	1
5	Treatment of Hypertension with Nutrition and Nutraceutical Supplements: Part 2 2019 ·Alternative and Complementary Therapies ·Mark C. Houston	5
6	Treatment of Hypertension with Nutrition and Nutraceutical Supplements: Part 1 2018 ·Alternative and Complementary Therapies ·Mark C. Houston	8
7	The Role of Mercury in Cardiovascular Disease 2014 ·Mark C. Houston	20
8	Potassium, Magnesium, and Calcium: Their Role in Both the Cause and Treatment of Hypertension 2008 ·Journal of Clinical Hypertension ·Mark C. Houston, Karen Harper	191
9	The role of mercury and cadmium heavy metals in vascular disease, hypertension, coronary heart disease, and myocardial infarction. 2007 ·PubMed ·Mark C. Houston	202
10	Treatment of hypertension with nutraceuticals, vitamins, antioxidants and minerals 2007 ·Expert Review of Cardiovascular Therapy ·Mark C. Houston	26
11	Juice Powder Concentrate and Systemic Blood Pressure, Progression of Coronary Artery Calcium and Antioxidant Status in Hypertensive Subjects: A Pilot Study 2006 ·Evidence-based Complementary and Alternative Medicine ·Mark C. Houston, Bruce Cooil, (unknown), Paolo Raggi	15
12	Addressing the Global Cardiovascular Risk of Hypertension, Dyslipidemia, Diabetes Mellitus, and the Metabolic Syndrome in the Southeastern United States, Part II: Treatment Recommendations for Management of the Global Cardiovascular Risk of Hypertension, Dyslipidemia, Diabetes Mellitus, and the Metabolic Syndrome 2005 ·The American Journal of the Medical Sciences ·William H. Bestermann, Mark C. Houston, Ralph G. Hawkins, (unknown), (unknown), Dan Lackland, Carlos M. Ferrario, (unknown), James Reed, (unknown), (unknown)	54
13	A free-ranging roundtable discussion on hypertension 2005 ·Journal of Human Hypertension ·John B. Standridge, J E Sealey, John H. Laragh, Mark C. Houston, (unknown), R. J. Johnson, Jon D. Blumenfeld, (unknown), Bridget Egan, Jay I. Meltzer, (unknown), Taku Fujita	1
14	EFFICACY AND SAFETY OF ATORVASTATIN PLUS AMLODIPINE VERSUS EITHER AGENT ALONE IN PATIENTS WITH CONCOMITANT DYSUPIDEMIA AND HYPERTENSION 2004 ·Journal of Hypertension ·J. Flack, (unknown), Mark C. Houston, J NEUTEL, (unknown), David Gillen, E Gibson	6
15	Alpha₁-blocker combination therapy for hypertension 1998 ·Postgraduate Medicine ·Mark C. Houston	2
16	Pest problems: The view of New Zealand federated farmers 1993 ·New Zealand Journal of Zoology ·Mark C. Houston	4
17	Nonsteroidal anti-inflammatory drugs and antihypertensives 1991 ·The American Journal of Medicine ·Mark C. Houston	113
18	The effects of clonidine hydrochloride versus atenolol monotherapy on serum lipids, lipid subfractions, and apolipoproteins in mild hypertension 1990 ·American Heart Journal ·Mark C. Houston, (unknown), J. Taylor Hays, John Nadeau, Larry L. Swift, Charles Bradley, (unknown)	8
19	Pathophysiology, clinical aspects, and treatment of hypertensive crises 1989 ·Progress in Cardiovascular Diseases ·Mark C. Houston	32
20	Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseases 1988 ·American Heart Journal ·Mark C. Houston, (unknown)	49

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact